mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
Linde Schoenmaker(Leiden University), Daan J.A. Crommelin(Utrecht University)
Cited by 1,446
Related Papers
Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?
|Journal of Pharmaceutical Sciences|2021|104